Skip to content

Effects and Neural Mechanisms of Repeated Transcranial Electrical Stimulation in Chronic Pain: A Randomized Controlled Study

Research on the Regulation of Chronic Pain by Transcranial Electrical Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122649
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

tRNS treatment group:A 3-day pain intervention on the contralateral M1, with daily sessions of 20 minutes. Stimulation pattern: tRNS + DC-offset, current intensity: 1 mA tRNS + 1 mA DC-offset.
tDCS treatment group:A 3-day pain intervention on the contralateral M1, with daily sessions of 20 minutes. Stimulation pattern: anodal tDCS, current intensity: 1 mA.

Sponsors

Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18–75 years; 2.Pain Duration: Pain persists or recurs for more than 3 months; 3.Pain Location: Pain in clearly localized superficial areas of the trunk or limbs (e.g., neck, shoulder, back, waist, knee, etc.); 4.Pain Intensity: Pain intensity at screening and enrollment, as measured by the Numeric Rating Scale (NRS), scores =30/100; 5.Cognitive Ability and Compliance: Sufficient cognitive ability to understand the study content, voluntarily sign the informed consent form, and commit to complying with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Pain with special etiologies: Pain with clearly defined specific causes, including but not limited to: (1) Cancer pain. (2) Visceral-origin pain. 2. Significant comorbid diseases: (1) History of neurological diseases (such as epilepsy, sequelae of stroke, Parkinson's disease, multiple sclerosis, etc.). (2) History of psychiatric disorders (such as major depressive episodes, bipolar disorder, schizophrenia, etc.). (3) Major organ diseases involving the heart, lungs, liver, kidneys, etc. 3. Recent interventions that may affect efficacy evaluation or safety: (1) Receiving other invasive or non-invasive neuromodulation treatments (such as tDCS, transcranial magnetic stimulation, spinal cord stimulation, etc.) within the past month. (2) Undergoing surgery or major invasive treatment for pain within the past month. (3) Presence of intracranial metal implants, cardiac pacemakers, or other contraindications to transcranial electrical stimulation. 4. Other exclusion criteria: (1) Women who are pregnant or breastfeeding. (2) History of alcohol or drug abuse/dependence. (3) Any other conditions that, in the investigator's judgment, may affect participation in the study or the reliability of data.

Design outcomes

Primary

MeasureTime frame
Pain intensity;Pain unpleasantness;

Secondary

MeasureTime frame
Pain sensitivity trait;Conditioned pain modulation;Temporal summation of pain;fMRI resting-state brain activity;

Countries

China

Contacts

Public ContactXiaoyun Li

Shenzhen University

lxyevelynli@gmail.com+86 131 0696 9670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026